Source: Annual Congress 2005 - Treatment of pulmonary and extrapulmonary tuberculosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
E. C. Seyhan, E. Cetinkaya, A. Gencoglu, G. Safak, P. Ozkan, S. Altin (Istanbul, Turkey). Value of aprotinin and tranexamic acid for massive hemoptysis in pulmonary tuberculosis patients. Eur Respir J 2005; 26: Suppl. 49, 4094

Member's Comments

No comment yet.

Related content which might interest you: Treatment of hemoptysis in inoperable patients with pulmonary aspergilloma: Value of percutaneous instillation of fluconazole Source: Annual Congress 2013 –Interesting cases of respiratory infections Year: 2013 The causes of hemoptysis and lung hemorrhage in patients with pulmonary sarcoidosis Source: Annual Congress 2011 - Acute respiratory failure Year: 2011 Effectiveness of anticoagulation with unfractionated heparin for acute pulmonary embolism Source: Virtual Congress 2021 – Insights into pulmonary embolism Year: 2021 Long term effect of bronchial arterial embolization in hemoptysis patients by pulmonary tuberculosis sequelae Source: Eur Respir J 2006; 28: Suppl. 50, 305s Year: 2006 Argonplasma coagulation in surgery of pulmonary tuberculosis Source: Annual Congress 2012 - Surgery for infections and congenital diseases Year: 2012 Fibrinolysis with tenecteplase in the management of massive pulmonary embolism Source: Eur Respir J 2004; 24: Suppl. 48, 559s Year: 2004 Effect of bronchial artery embolization (BAE) on the management of hemoptysis associated with pulmonary tuberculosis; factors influencing recurrent hemoptysis Source: Annual Congress 2008 - Infectious lung diseases including tuberculosis Year: 2008 Non-bronchial systemic arterial embolization in management of massive hemoptysis secondary to post-tuberculous bronchiectasis in Egypt Source: Annual Congress 2010 - Vascular and solitary lesions Year: 2010 A clinical comparison of intrapleural heparin versus urokinase in the management of tuberculous pleurisy Source: Eur Respir J 2005; 26: Suppl. 49, 647s Year: 2005 Treatment of ulcerative endobronchial tuberculosis and bronchial stenosis with aerosolized streptomycin and steroids Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001 Intravenous ozon in pulmonary tuberculosis Source: Eur Respir J 2005; 26: Suppl. 49, 650s Year: 2005 Role of electrocardiography score in massive and non-massive pulmonary thromboembolism Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease Year: 2008 Intratumoral injection of tranexamic acid for control of biopsy-induced bleeding: Two years‘ experience of a new bronchoscopic technique Source: Annual Congress 2012 - The different ways to establish a diagnosis: needle and forcep Year: 2012 The treatment of sub massive pulmonary embolism: Thrombolytic or heparin? Source: Annual Congress 2012 - Pulmonary circulation: acute and chronic pulmonary embolism Year: 2012 Surgical management of bronchiolithiasis due to tuberculosis with hemoptysis Source: Eur Respir J 2006; 28: Suppl. 50, 10s Year: 2006 Comparison of local and systemic thrombolytic treatment for acute massive pulmonary embolism Source: Eur Respir J 2007; 30: Suppl. 51, 544s Year: 2007 The outcome of anticoagulation alone therapy for patients with submassive pulmonary embolism Source: International Congress 2019 – Epidemiology and management of acute pulmonary embolism Year: 2019 Treatment results of cases of severe pulmonary tuberculosis with using rifabutin Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001 Comparison of long –term outcomes of 50 mg rt-PA and 100 mg rt-PA in the management of acute pulmonary embolism Source: International Congress 2016 – Acute pulmonary embolism Year: 2016 Massive haemoptysis in a patient with melioidosis Source: International Congress 2019 – Pulmonary vascular diseases? Year: 2019